10-day Decitabine Versus Conventional Chemotherapy ("3+7") Followed by Allografting in AML Patients greater than or equal to 60 Years: a Randomized Phase III Study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group
Phase of Trial: Phase III
Latest Information Update: 12 Aug 2019
Price : $35 *
At a glance
- Drugs Decitabine (Primary) ; Cytarabine; Daunorubicin; Etoposide; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 10 Sep 2017 This trial has been completed in Bulgaria, as per European Clinical Trials Database record.
- 14 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 06 Aug 2014 New trial record